Ipsen Pharma (SAS) Posted July 27, 2026

Senior Global Medical Affairs Director, Medical Asset Lead, Hematology - Oncology (6 months Fixed Term Contract)

Paris, France Full time
Medical Affairs Oncology Director

Ipsen Pharma (SAS) is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

Title:

Senior Global Medical Affairs Director, Medical Asset Lead, Hematology - Oncology (6 months Fixed Term Contract)

Company:

Ipsen Pharma (SAS)

About Ipsen:

Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.

Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!

For more information, visit us at https://www.ipsen.com/   and follow our latest news on LinkedIn and Instagram .

Job Description:

About the Role: This is a 6-months Fixed Term Contract

The Senior Global Medical Affairs Director, Medical Asset Lead, Hematology - Oncology (6-months Fixed Term Contract) is a key strategic leader responsible for shaping the global medical vision and optimizing the full lifecycle of high-impact medical assets. In this senior role, you will drive the alignment of medical deliverables with the goals of the Global Asset Team.

Your leadership will extend to spearheading cross-functional Medical Asset sub-teams (MEG – Medical and Evidence Generation Team), where you will define, drive, and deliver a comprehensive, integrated medical strategy that aligns seamlessly with R&D, access, commercial, regulatory, manufacturing and key local market plans to support the global asset strategies.

This is a unique opportunity to influence pivotal decision-making and elevate our global impact through every phase of the asset lifecycle, ensuring its value to patients, healthcare providers, and stakeholders worldwide

Main Responsibilities

Key Deliverables:

Congress: booth content finalization, including unbranded campaign launch, TL touch plan coordination

EHA 2027 congress sponsorship finalization & preparation

Early IEGP finalization & support to PFR process

Publication plan coordination (manuscripts, abstracts/presentations)

Insight collection plan: urothelial cancer (ad board at ESMO), MDS (ad board before year end), US ad board at ASH

Data generation: research collaboration to be finalized for melanoma PoC, UC and ISS review coordination

Development of 2027 training plan

Coordination of thought leader interactions and insights, cooperative groups, scientific societies & investigational site mapping in collaboration with R&D and country medical affairs

Publication plan coordination: results for presentation at ASH & related Q&A materials, manuscripts

Study supervision

Publication plan coordination: Results for presentation at ASH & related Q&A materials, manuscripts

Study supervision

Medical Asset Lead responsibilities:

Define and deliver an integrated medical asset strategy and plan for both assets to address patient needs

Own the overall medical strategy, establishes project goals and leads a cross-functional team to meet the medical objectives.

Outline an integrated evidence generation plan (IEGP) that shapes the competitive and prescription landscape.

Integrate and influence the medical content of Knowledge Transfer, Medical Education and Information, Congress Management and KOL/TL engagements.

Translate the medical plan into an efficiently executable high-level roadmap with clear priorities.

Oversee GMA-led clinical trial executions, ensure a strong alignment with all functions, and drive operational excellence in execution.

Accountable for leading MEG in coordination with R&D, market access and commercial activities

Develop and manage strong relationships with internal and external stakeholders

Role model and ambassador for the Medical Asset Plan and for IPSEN with our internal partners and external collaborators, with representatives from the scientific community and health authorities, and in any interactions with health care practitioners and patients

Serve as the spokesperson for the Medical Asset Plan, reporting progress, risks and issues to functional and executive leaders.

Represent the interests of the Medical Asset at the Governance Committee

Manage the respective medical asset budget

Oversee the medical asset budget, from planning and reporting

Manage projects prioritization within the budget

Provide strong insights for arbitration within the activities

Ethics & Compliance

Complete all above activities within the framework and in compliance with all relevant Ipsen SOPs, external GCPs and guidelines as well as other relevant policies in force within the Ipsen Group or under national and/or international authorities under which jurisdiction Ipsen is operating.

Qualifications

MD; PhD with strong relevant industry experience

Extensive experience in Hematology-Oncology

Extensive pharmaceutical experience in significant clinical/medical leadership or general management positions including working with R&D, market access, commercialization and manufacturing teams leading and influencing teams, both in a direct and indirect setting

Experience between in-country marketing roles and regional/global brand or franchise leadership positions preferred

Market-relevant experience of hemato-oncology therapy area, including the competitive landscape and Key External Experts

International experience preferred.

Track record of successful product launches within the respective therapy area.

Strong business and/or medical experience in one of the top 5 European markets (UK, France, Germany, Spain, Italy) or in North America (US, Canada)

Fluency in Englis

#LI-HYBRID

Nous nous engageons à créer un lieu de travail où chacun se sent écouté, valorisé et soutenu, où nous incarnons « The Real Us*». La valeur que nous accordons aux différentes perspectives et expériences motive notre engagement en faveur de l'inclusion et de l'égalité des chances. Lorsque nous intégrons des modes de pensée diversifiés, nous prenons des décisions plus réfléchies et découvrons des solutions plus innovantes. Ensemble, nous nous efforçons de mieux comprendre les communautés que nous servons. Cela signifie que nous voulons également vous aider à donner le meilleur de vous-même lorsque vous postulez à un poste chez nous. Si vous avez besoin d'aménagements ou d'aide pendant le processus de candidature, veuillez en informer l'équipe de recrutement. Ces informations seront traitées avec soin et n'auront aucune incidence sur le résultat de votre candidature. *Soyons nous-même

Job details

Seniority
Director
Function
Medical Affairs
Therapeutic area
Oncology
Location
Paris, France
Employment type
Full time

How this role compares

Computed from every other active Medical Affairs role in our database, not just this employer's listings.

We currently track 237 comparable Director Medical Affairs roles across 43 biopharma companies.

237Comparable roles tracked
224Currently active
43Companies hiring similar roles
19Countries represented

Salary context

124 of 237 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject Not listed on this posting
Peer group range $163,125 – $392,100 (median $260,974)

Where these roles are based

Top locations among the 237 comparable roles

United States176
United Kingdom17
China's Mainland8
Japan7
Switzerland6
Spain3

+ 13 more countries

Seniority mix

237 of 237 peers have a known seniority level

Director207
Senior Director24
Principal6

Therapeutic area mix

112 of 237 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology45
Immunology17
Neuroscience15
Respiratory9
Dermatology & Aesthetics8
Rare Disease7
Cardiovascular / CVRM7
Vaccines & Infectious Disease2
Ophthalmology1
Gastroenterology1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

85%similar
Roche Shanghai, Shanghai, China's Mainland Director
Same function Same therapeutic area Same seniority
85%similar
Roche Shanghai, Shanghai, China's Mainland Director
Same function Same therapeutic area Same seniority
85%similar
AbbVie Director
Same function Same therapeutic area Same seniority

Open in 3 locations

Mettawa, United StatesFlorham Park, United StatesSan Francisco, United States
85%similar
AbbVie Florham Park, NJ Director
Same function Same therapeutic area Same seniority
85%similar
AbbVie Director
Same function Same therapeutic area Same seniority

Open in 4 locations

Waltham, United StatesNorth Chicago, United StatesFlorham Park, United StatesSouth San Francisco, United States

Notify me about similar jobs

Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

85%
Early Development Lead Medical Director, Non-oncology
Roche · Shanghai, Shanghai, China's Mainland · Director
Function Therapeutic area Seniority Country
85%
Scientific Director / Senior Medical Director, Multiple Myeloma (International Medical Affairs)
AbbVie · Florham Park, NJ · Director
Function Therapeutic area Seniority Country
85%
Senior Medical Director, Oncology Early Development
AbbVie · Waltham, MA · Director
Function Therapeutic area Seniority Country
85%
Senior Medical Director, Oncology Early Development
AbbVie · South San Francisco, CA · Director
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.